Hemophilia Inhibitor Genetics Study (HIGS)

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

NCT05022459 ·Status: RECRUITING

Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

NCT02540187 ·Status: COMPLETED

Bleeding Symptoms of Carriers of Hemophilia A and B

NCT01029808 ·Status: COMPLETED

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

NCT04158648 ·Status: COMPLETED ·Phase: PHASE3

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)

NCT05685238 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

ASC618 Gene Therapy in Hemophilia A Patients

NCT04676048 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Prophylaxis Regimen for Hemophilia A Patients

NCT05036278 ·Status: COMPLETED ·Phase: PHASE4

Weight-based Dosing in Hemophilia A

NCT02586012 ·Status: TERMINATED ·Phase: PHASE2

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

NCT00621673 ·Status: TERMINATED ·Phase: PHASE4

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

NCT06155955 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Low Dose Emicizumab vs Low Dose Factor VIII in Prophylaxis in Hemophilia A Patients

NCT06938659 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis

NCT04583930 ·Status: UNKNOWN

Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors

NCT02453542 ·Status: RECRUITING

Canadian Hemophilia Prophylaxis Study

NCT01085344 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

NCT04165135 ·Status: COMPLETED

Epidemiology and Immunology of Hemophilia A Inhibitors

NCT00005518 ·Status: COMPLETED

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

NCT04456387 ·Status: COMPLETED ·Phase: PHASE3

TFPI Levels in Haemophilia A and B Patients

NCT04570696 ·Status: UNKNOWN

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

A Feasibility Study to Collect Data in Patients With Haemophilia

NCT00798499 ·Status: COMPLETED

Are There Differences Between Carriers of Haemophilia A and B?

NCT05217992 ·Status: COMPLETED

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

NCT01626105 ·Status: UNKNOWN

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

NCT00178607 ·Status: COMPLETED